Table 3.
Group | Condomless Intercourse with 2+ Steady Men, Last 12m | Sex of any Kind with 5+ Non-Steady Men, Last 12m | Condomless Intercourse with 1+ Non-Steady Man of Unknown HIV Status, Last 12m | ||||||
---|---|---|---|---|---|---|---|---|---|
% | OR (95% CI), Unadjusted | OR (95% CI), Adjusted * | % | OR (95% CI), Unadjusted | OR (95% CI), Adjusted * | % | OR (95% CI), Unadjusted | OR (95% CI), Adjusted * | |
AMB men N = 124,838 | 8.5 | 1.00 | 1.00 | 45.1 | 1.00 | 1.00 | 23.9 | 1.00 | 1.00 |
AMB trans men N = 373 | 14.0 | 1.74 (1.29–2.34) | 1.67 (1.24–2.26) | 39.3 | 0.75 (0.61–0.93) | 0.75 (0.60–0.93) | 20.2 | 0.80 (0.62–1.04) | 0.79 (0.61–1.01) |
AFB trans men N = 498 | 3.7 | 0.41 (0.26–0.65) | 0.44 (0.28–0.71) | 13.3 | 0.19 (0.14–0.24) | 0.21 (0.17–0.28) | 13.3 | 0.49 (0.38–0.63) | 0.51 (0.39–0.66) |
AFB men N = 178 | 7.5 | 0.87 (0.49–1.53) | 0.91 (0.52–1.60) | 25.6 | 0.42 (0.30–0.59) | 0.46 (0.32–0.64) | 8.5 | 0.30 (0.17–0.50) | 0.30 (0.18–0.51) |
Group | Stimulant Drugs Used to Make Sex Last Longer or More Intense, Last 4 Weeks | Injected Drugs to Get High, Last 12m | Currently Taking PrEP (among those not Diagnosed HIV Positive) | ||||||
% | OR (95% CI), Unadjusted | OR (95% CI), Adjusted * | % | OR (95% CI), Unadjusted | OR (95% CI), Adjusted * | % | OR (95% CI), Unadjusted | OR (95% CI), Adjusted * | |
AMB men N = 124,838 | 5.3 | 1.00 | 1.00 | 1.2 | 1.00 | 1.00 | 3.1 | 1.00 | 1.00 |
AMB trans men N = 373 | 3.6 | 0.67 (0.39–1.17) | 0.64 (0.37–1.12) | 0.8 | 0.70 (0.22–2.17) | 0.63 (0.20–1.97) | 2.6 | 0.84 (0.43–1.63) | 0.81 (0.42–1.58) |
AFB trans men N = 498 | 2.6 | 0.49 (0.28–0.84) | 0.55 (0.31–0.96) | 1.0 | 0.86 (0.36–2.08) | 1.01 (0.42–2.45) | 1.0 | 0.32 (0.13–0.78) | 0.39 (0.16–0.93) |
AFB men N = 178 | 2.3 | 0.43 (0.16–1.14) | 0.46 (0.17–1.23) | 0.0 | – | – | 1.8 | 0.57 (0.18–1.77) | 0.63 (0.20–1.97) |
OR = Odds ratio; CI = Confidence Interval; * adjusted for age, country and employment; emboldened results are significant at p < 0.05 after adjustment.